600-Million-Dollar Medicine Quarrel

A medicine quarrel continued between international and local manufacturers on the issue of “data privilege.” Data privilege is a kind of privilege that provides monopoly to the investigator firm of the medicine.International manufacturers insisted on the data privilege as a result of the harmonization laws to the European Union. National manufacturers asserted that if the data privilege was accepted before 2007, the loss of Turkish exports will be 600 million dollars per year.�